Linda Nicolardi

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

Alessio Cortellini, Marco Tucci, Vincenzo Adamo et al. · Journal for ImmunoTherapy of Cancer · 2020 · 264 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas

Livio Trentin, Anna Cabrelle, Monica Facco et al. · Blood · 2004 · 148 citations · Full text

Life Sciences, Immunology, Oncology +14

How effective is BCNU in recurrent glioblastoma in the modern era?

Alba A. Brandes, A. Tosoni, Pietro Amistà et al. · Neurology · 2004 · 131 citations

Medicine, Oncology, Pharmacotherapy +17

Second-Line Chemotherapy With Irinotecan Plus Carmustine in Glioblastoma Recurrent or Progressive After First-Line Temozolomide Chemotherapy: A Phase II Study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Alba A. Brandes, Alicia Tosoni, Umberto Basso et al. · Journal of Clinical Oncology · 2004 · 123 citations · Full text

Medicine, Oncology, Pharmacology +17

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone et al. · European Journal of Cancer · 2020 · 117 citations

Life Sciences, Immunology, Oncology +17